Prospects for vaccine development

The Revised Authoritative Guide To Vaccine Legal Exemptions

Vaccines Have Serious Side Effects

Get Instant Access

The application of molecular biologic techniques over the past decade has seen a tremendous growth in our knowledge of the biology of E. histolytica, and has led to the identification and structural characterization of three potential amoebic vaccine antigens: the serine-rich E. histolytica protein (SREHP), the 170-kDa subunit of the Gal/GalNAc binding lectin, and the 29-kDa cysteine-rich protein. Such a putative vaccine may be an oral combination 'enteric pathogen' vaccine, capable of inducing protective mucosal immune responses to several clinically important enteric pathogens, including E. histolytica (Ryan et al. 1997; Stanley 1997). An understanding of the amoeba's obligatory encystment pathway should provide an approach for interrupting the transmission (Eichinger 1997).

Was this article helpful?

0 0

Post a comment